Sign Up to like & get recommendations! 1
Published in 2022 at "Pediatric Pulmonology"
DOI: 10.1002/ppul.26114
Abstract: Our aim was to determine whether early chronic methicillin‐susceptible Staphylococcus aureus (MSSA) colonization in children with cystic fibrosis (CF) is associated at 8 years of age with poorer lung function, poorer nutritional status, and increased… read more here.
Sign Up to like & get recommendations! 0
Published in 2017 at "Infectious Diseases and Therapy"
DOI: 10.1007/s40121-017-0148-z
Abstract: IntroductionAnti-staphylococcal penicillins are generally accepted as first-line therapy for methicillin-susceptible Staphylococcus aureus (MSSA) bacteremia, but their use may be limited by interstitial nephritis and acute kidney injury. Alternatives include first-generation cephalosporins including cefazolin.MethodsWe conducted a… read more here.
Sign Up to like & get recommendations! 0
Published in 2018 at "Journal of infection and public health"
DOI: 10.1016/j.jiph.2018.02.004
Abstract: BACKGROUND Anti-staphylococcal penicillins have long been the first-line treatment option for methicillin-susceptible Staphylococcus aureus (MSSA) infections. Recent retrospective data comparing nafcillin and cefazolin report similar clinical efficacy despite concerns about high inoculum MSSA infections. METHODS… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "Antimicrobial Agents and Chemotherapy"
DOI: 10.1128/aac.02166-21
Abstract: Cefazolin and ertapenem have been shown to be an effective salvage regimen for refractory methicillin-susceptible Staphylococcus aureus bacteremia. Our findings suggest cefazolin plus ertapenem in vitro stimulates interleukin-1β release from peripheral blood monocytes both with… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "Journal of Clinical Microbiology"
DOI: 10.1128/jcm.02495-21
Abstract: Antistaphylococcal penicillins and cefazolin remain the primary treatments for infections with methicillin-susceptible Staphylococcus aureus (MSSA). The cefazolin inoculum effect (CzIE) causes the cefazolin MIC to be elevated in proportion to the number of bacteria in… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "Microbiology Spectrum"
DOI: 10.1128/spectrum.01039-22
Abstract: Cephalexin and cefadroxil are oral antibiotics that are used to treat serious infections due to the bacteria MSSA. While cephalexin is used more commonly, cefadroxil is excreted from the body more slowly; this generally allows… read more here.
Sign Up to like & get recommendations! 0
Published in 2018 at "Chemotherapy"
DOI: 10.1159/000499033
Abstract: Background: Antistaphylococcal penicillins have historically been regarded as the drugs of choice for methicillin-susceptible Staphylococcus aureus (MSSA) bloodstream infections (BSI). However, recent outcomes data compared to cefazolin treatment are conflicting. Objective: This study compared treatment… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "Yonsei Medical Journal"
DOI: 10.3349/ymj.2022.63.7.611
Abstract: Purpose This study aimed to provide compelling evidence of anti-staphylococcal beta-lactam use for methicillin-susceptible Staphylococcus aureus bloodstream infection (MSSA BSI). Materials and Methods We retrospectively collected data on patients with MSSA BSI who were admitted… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "Antibiotics"
DOI: 10.3390/antibiotics11030375
Abstract: (1) Background: Ceftriaxone is a potential alternative for the treatment of methicillin-susceptible Staphylococcus aureus (MSSA) bloodstream infections (BSIs) in acute care and outpatient parenteral antimicrobial therapy (OPAT) settings. We evaluated the effectiveness and safety of… read more here.